| Name | WAY-328158 |
|---|---|
| Synonyms |
3-Isoxazolecboxamide, N-[3-(aminocbonyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]-5-(4-fluorophenyl)
N-(3-Cbamoyl-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-5-(4-fluorophenyl)isoxazole-3-cboxamide |
| Description | BCR-ABL-IN-7 (compound 4) is a WT and T315I mutant ABL kinases inhibitor. BCR-ABL-IN-7 effectively inhibits activities of WT and T315I mutant ABL kinases. BCR-ABL-IN-7 can be used for the research of chronic myeloid leukemia (CML) research[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C19H16FN3O3S |
|---|---|
| Molecular Weight | 385.41 |